Tarsus Pharmaceuticals (TARS) Inventory (2023 - 2026)

Tarsus Pharmaceuticals' Inventory history runs 4 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• In Q1 2026, Inventory rose 69.02% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (up 69.02% YoY), while the FY2025 annual figure was $4.4 million, up 66.87% from the prior year.
• Inventory was $4.6 million for Q1 2026 at Tarsus Pharmaceuticals, up from $4.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $4.6 million in Q1 2026 to a low of $15000.0 in Q3 2023.
• Historically, Inventory has averaged $3.1 million across 4 years, with a median of $3.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Inventory soared 18873.33% in 2024, then tumbled 32.98% in 2025.
• A 4-year view of Inventory shows it stood at $3.1 million in 2023, then declined by 15.67% to $2.6 million in 2024, then surged by 66.87% to $4.4 million in 2025, then gained by 4.57% to $4.6 million in 2026.
• The last three Inventory figures came in at $4.6 million (Q1 2026), $4.4 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.